000 | 01809 a2200505 4500 | ||
---|---|---|---|
005 | 20250513135341.0 | ||
264 | 0 | _c19980309 | |
008 | 199803s 0 0 eng d | ||
022 | _a0003-9950 | ||
024 | 7 |
_a10.1001/archopht.116.2.178 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, I L | |
245 | 0 | 0 |
_aClinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. _h[electronic resource] |
260 |
_bArchives of ophthalmology (Chicago, Ill. : 1960) _cFeb 1998 |
||
300 |
_a178-85 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 | _aCidofovir |
650 | 0 | 4 |
_aCytomegalovirus _xdrug effects |
650 | 0 | 4 |
_aCytomegalovirus Retinitis _xdrug therapy |
650 | 0 | 4 |
_aCytosine _xanalogs & derivatives |
650 | 0 | 4 |
_aDNA, Viral _xanalysis |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 |
_aGanciclovir _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOrganophosphonates |
650 | 0 | 4 |
_aOrganophosphorus Compounds _xtherapeutic use |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aVitreous Body |
700 | 1 | _aTaskintuna, I | |
700 | 1 | _aRahhal, F M | |
700 | 1 | _aPowell, H C | |
700 | 1 | _aAi, E | |
700 | 1 | _aMueller, A J | |
700 | 1 | _aSpector, S A | |
700 | 1 | _aFreeman, W R | |
773 | 0 |
_tArchives of ophthalmology (Chicago, Ill. : 1960) _gvol. 116 _gno. 2 _gp. 178-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/archopht.116.2.178 _zAvailable from publisher's website |
999 |
_c9456432 _d9456432 |